sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
»ùÒòÐÞÊιÚ×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯Îï
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > »ùÒòÐÞÊιÚ×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯Îï

ǰÑÔ

ÈËÀàȱѪÐÔÐÄÔಡ°üÀ¨ÐĽÊÍ´ºÍÐ£ËÀ £¬²¢Çһᱬ·¢Ðļ¡ÏËά»¯ºÍÐÄË¥ ¡£µ¼ÖÂÐļ¡È±ÑªµÄ×î³£¼ûÔµ¹ÊÔ­ÓÉÊÇÖ¸¹Ú×´¶¯ÂöÖàÑùÓ²»¯»ù´¡ÉÏ £¬¹Ú×´¶¯Âö¾·ÂλòÛÕ±Õµ¼ÖÂÐļ¡È±ÑªÈ±Ñõ»ò»µËÀ £¬¼´¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ(coronary atherosclerotic heart disease) £¬¼ò³Æ¹ÚÐIJ¡ ¡£Ëü²»µ«ÔÚÅ¹ú¼Ò³£¼û £¬ÔÚÎÒ¹úÒ²³ÊÖðÄêÔöÌíÇ÷ÊÆ £¬½üÄêÀ´³ÉΪÎÒ¹úéæÃüÂÊǰÁ½Î»µÄ¼²²¡Ö®Ò» ¡£Õë¶Ô¹ÚÐIJ¡µÄÒ©ÎïÆÀ¼Û £¬Ò»Ö±Ã»ÓкÜÀû±ãÊÊÓõ͝ÎïÄ£×Ó £¬Ö÷ÒªÓÉÓÚ±£´æÒ»Ð©Ç·ºÃ½â¾öµÄÄÑÌâ ¡£Ê×ÏÈ £¬ÊÖÊõÓÕ·¢ÀàµÄÄ£×Ó £¬ÊÖÒÕÄѶȴó £¬ÌØÊâÔÚС¶¯ÎïÉϲÙ×÷µÄÒ»ÖÂÐÔÇ·ºÃ¿ØÖÆ £¬¶ø´ó¶¯Îï¹ØÓÚÒ©ÎïÆÀ¼Û²»ÊǺܱ㵱 £¬Ð¡¶¯Îïͬʱ»¹±£´æÐĵç¼à¿ØµÈרҵÒÇÆ÷µÄÏÞÖÆ ¡£ÁíÍâ £¬ÈËÀàÐÄѪ¹ÜÏµÍ³ÌØµãÒÔ¼°ÔÚijЩÇéÐÎÒòËØ£¨ÈçÓ¦¼¤£©Ï·¢²¡µÄÌØµã £¬ÔÚ³£ÓõÄС¶¯ÎïÄ£×ÓÉ϶¼ºÜÄÑÄ£Äâ £¬ÏÖÓÐÄ£×ÓºÍÈËÀ༲²¡µÄÏÖÕæÏàÐβî±ðºÜ´ó ¡£¾¡¿ÉÄÜÄ£ÄâÈËÀ༲²¡µÄ²¡ÒòºÍ²¡Àí»úÖÆ £¬ÎªÑ°ÕÒȱѪÐÔÐÄÔಡµÄ·ÀÖβ½·¥ÌṩºÜºÃµÄÑо¿Æ½Ì¨ £¬ÊÇÕâÀàÄ£×ÓÑо¿µÄÉú³¤Æ«Ïò ¡£

ÓÉÓÚСÊó¶¯ÂöÖàÑùÓ²»¯²¡±äµÄ²¿Î»¾ÖÏÞÓÚ×Ô¶¯Âö £¬Í¨Ë×ÔìÄ£·½·¨²»¿ÉÄ£ÄâÈËÀà¹ÚÐIJ¡×ÔÈ»·¢²¡Àú³Ì £¬Òò´ËСÊóµÄ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ÐÔÐÄÔಡģ×Ó £¬ÖƱ¸ºÜÊÇÄÑÌâ ¡£ÔÚ»ùÒòÐÞÊÎСÊóÄ£×Ó´ó×Ú·ºÆðÒÔºó £¬Ò»Ð©ÌØÊâµÄÄ£×ÓÖð½¥±»·¢Ã÷ÓÐ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐ£ËÀ»òÕß¾ßÓÐÇéÐÎÖ²¡ÒòËØÒ׸ÐÐÔ ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

 Í¨¹ý¶à»ùÒòÐÞÊÎ £¬ÔÚÓ°ÏìÖ¬´úл¡¢Ñª¹Ü±Úϸ°ûµÈ¶àÖÖ»ùÒò¹¦Ð§Òì³£ÇéÐÎÏ £¬Ôì³ÉºÜÊÇÑÏÖØµÄ¶¯ÂöÖàÑùÓ²»¯ £¬Ê¹²¡±äÖð½¥ÀÛ¼°ÐÄÄÔѪ¹Ü ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

¶à»ùÒòÐÞÊλù´¡ÉÏ £¬ÔöÌíÒûʳ»òÓ¦¼¤µÈÇéÐÎÒòËØ £¬Ä£ÄâÈËÀà¹Ú×´¶¯ÂöÓ²»¯×ÔÈ»±¬·¢Àú³Ì ¡£

¡¾ÔìÄ£ÌØµã¡¿£º

SR-BI/ApoEË«»ùÒòÇóýСÊó·ºÆðÏÔÖøÉý¸ßµÄ¸ßÃܶÈÖ¬ÂÑ°× £¬¶øÓÎÀ뵨¹Ì´¼ÏÔÖøÉý¸ß £¬Ñª½¬ÖÐ £¬ÆäÓ뵨¹Ì´¼º¨µÄ±ÈÀý(FC/CE)ÏÔÖøÉý¸ß³ÉΪ¸ÃÄ£×ÓµÄÌØµã ¡£¸ÃÄ£×Ó8ÖÜÄÚ»ù±¾¶¼·ºÆð¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐĹ£ £¬éæÃüÂʼ«¸ß ¡£n/i/eNOSÈý»ùÒòÇóýСÊó³öÉú8¸öÔÂ×óÓÒ°ëÊýÒÔÉÏËÀÓÚÐĹ£ ¡£¸ÃÄ£×ÓѪ½¬µÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼º¬Á¿Éý¸ß £¬¹Ú×´¶¯Âö±¬·¢ÏÔ×ŵÄÄÚĤÔöÉúºÍÖÐĤ±äºñ £¬¹ÜÖܰé·Ê´óϸ°û½þÈó £¬ÍƲâ¹Ú×´¶¯ÂöÓ²»¯ºÏ²¢¾·Âε¼Ö¸ÃÄ£×ÓÐĹ£ ¡£

ÏÂÃæËùÁеÄÄ£×Ó £¬¾ùÒѾ­±¨µÀÔÚÇéÐÎÒòËØ×÷ÓÃÏ £¬ÌåÏÖ¹Ú×´¶¯ÂöÓ²»¯ºÍÐĹ£ £¬°üÀ¨eNOS/ApoEË«ÇóýСÊó¡¢SR-BI-/-/HypoEСÊó¡¢SR-BI/LDLrË«ÇóýСÊó¡¢uPA-Tg/ApoE-/-СÊó¡¢Akt1/ApoEË«ÇóýСÊó¡¢PDZKI/ApoEË«ÇóýСÊó¡¢ApoE/LDL-RË«ÇóýСÊó ¡£ÕâЩģ×ÓÓи÷×ÔÏà¹ØµÄÖ¬´úÐ»ÌØµã £¬Í¬Ê±¾ßÓÐÔÚ¸ßÖ¬ÒûʳµÈÒòËØµÄ¸ººÉÏ £¬Ò»¶¨Ë®Æ½ÉÏ £¬ÈËΪ¿ØÖÆÐĹ£µÄ±¬·¢Ê±¼äºÍ¹Ú×´¶¯Âö²¡±äˮƽ ¡£

¡¾Ä£×ÓȪԴ¡¿£º

´ó´ó¶¼Ð¡ÊóÄ£×Ó¿ÉÒÔ´ÓÃÀ¹úJacksonʵÑéÊÒ(bttp://www.jax.org/index.html)¡¢MMRRC (Mutant Mouse Regional Resource Centers £¬http:// www.mmrrc.org)ºÍ¹ú¼ÒÒÅ´«¹¤³ÌСÊó×ÊÔ´¿â(http://www.nrcmm.cn/mice/index.asp)»ñµÃ ¡£´Ó±±¾©´óѧҽѧ²¿ÐÄѪ¹ÜÑо¿Ëù¿ÉÒÔ»ñµÃ²¿·Ö¶¯ÎïÄ£×Ó ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

 »ùÒòÐÞÊÎÊÖÒÕʹ¹ÚÐIJ¡Ð¡ÊóÄ£×ÓÖÆ±¸³ÉΪ¿ÉÄÜ £¬×÷ΪÈËÀà¹ÚÐIJ¡Ô¤·ÀºÍÖÎÁÆÑо¿µÄ¹¤¾ß £¬ÓÉÓÚСÊóÔÚÆÊ½â½á¹¹¡¢´úлµÈÐÄÀí¹¦Ð§µÄµ÷ÀíÉÏÓëÈËÀà±£´æ½Ï´ó²î±ð £¬Æä¹ÚÐIJ¡²¡±äÌØµãÓ벿λºÍÈËÀ಻ÍêȫһÖ £¬Ê¹µÃСÊóÄ£×ÓµÄÓ¦ÓÃÊܵ½Öî¶àÏÞÖÆ £¬ÆÀ¼ÛÐÂÒ©Ò²±£´æ½Ï´óΣº¦ ¡£

ÆäËû¶¯ÎïÈç´óÊó(JCR:LA-cp rat¡¢CETP Tg rat)¡¢µØÊó¡¢¼ÒÍᢸ롢ÖíÒÔ¼°·ÇÈËÁ鳤ÀàµÄºãºÓºï £¬¶¼ÓÐ×Ô¾õ¹Ú×´¶¯ÂöÓ²»¯µÄ±¨µÀ £¬ÌØÊâÊÇ×î½ü±¨µÀµÄPCSK9ת»ùÒòСÐÍÖí £¬ÓÉÓÚÖíÔÚÐÄѪ¹Ü¼²²¡Ä£×ÓÖеÄÌØÊâÓÅÊÆ £¬ÓпÉÄܳÉΪÀíÏëµÄ¹ÚÐIJ¡¶¯ÎïÄ£×Ó ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅ¿¡Òå £¬ÍõÕýÖÒ £¬´÷ºìÑÞ £¬µÈ£®´óÊóÐ£ËÀÄ£×ÓÖÆ×÷ÒªÁì̽ÌÖ£®Çൺ´óѧҽѧԺѧ±¨ £¬2013,49(2):121-123

2.¹ùˆÅ £¬ºÂΰ £¬Àî·å½Ü £¬µÈ£®BeagleÈ®ÓëÔÓÖÖÈ®¼±ÐÔÐ£ËÀÄ£×ӵĽÏÁ¿£®ÖйúÖÐÒ©ÔÓÖ¾ £¬2013,28 (12):2001-2004

3.Cozen  AE, Moriwaki H, Kremen M, el al. Macrophagetargeted overexpression of urokinase causes acceleratedatherosclerosis,coronary artery occlusions, and premature death. Circulation, 2004,09 (17):2129-2135

4.Cullen P,Baella R,Bellosla S,el al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vase Biol, 2003, 23 (4):535-542

5.Fernandez-Hernando C,Ackah E, Yu J,el al. Loss of Aktl leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab,2007, 6 (6):446-457

6.Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis,aortic aneurysm formation, and ischernic heart disease in apolipoprotein E/endolhelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104 (4):448-454

7.Nakata S, Tsutsui M, Shimokawa H,et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 2008, 117 (17):2211- 2223

8.Shiomi M,Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe., Atherosclerosis, 2009, 207 (1):1-7

9.Trigalli B, Rayburn H, Viiials M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A, 1999,96 (16):9322-9327

10.Zhang S,Picard MH, Vasile E,et al. Diel-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction,and premature death in scavenger receptor class B lype 1-deficient,hypomorphic apolipoprotein ER61 mice. Circulation, 2005, 111(25): 3457-3464

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > »ùÒòÐÞÊιÚ×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯Îï
»ùÒòÐÞÊιÚ×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ¶¯Îï

ǰÑÔ

ÈËÀàȱѪÐÔÐÄÔಡ°üÀ¨ÐĽÊÍ´ºÍÐ£ËÀ £¬²¢Çһᱬ·¢Ðļ¡ÏËά»¯ºÍÐÄË¥ ¡£µ¼ÖÂÐļ¡È±ÑªµÄ×î³£¼ûÔµ¹ÊÔ­ÓÉÊÇÖ¸¹Ú×´¶¯ÂöÖàÑùÓ²»¯»ù´¡ÉÏ £¬¹Ú×´¶¯Âö¾·ÂλòÛÕ±Õµ¼ÖÂÐļ¡È±ÑªÈ±Ñõ»ò»µËÀ £¬¼´¹Ú×´¶¯ÂöÓ²»¯ÐÔÐÄÔಡ(coronary atherosclerotic heart disease) £¬¼ò³Æ¹ÚÐIJ¡ ¡£Ëü²»µ«ÔÚÅ¹ú¼Ò³£¼û £¬ÔÚÎÒ¹úÒ²³ÊÖðÄêÔöÌíÇ÷ÊÆ £¬½üÄêÀ´³ÉΪÎÒ¹úéæÃüÂÊǰÁ½Î»µÄ¼²²¡Ö®Ò» ¡£Õë¶Ô¹ÚÐIJ¡µÄÒ©ÎïÆÀ¼Û £¬Ò»Ö±Ã»ÓкÜÀû±ãÊÊÓõ͝ÎïÄ£×Ó £¬Ö÷ÒªÓÉÓÚ±£´æÒ»Ð©Ç·ºÃ½â¾öµÄÄÑÌâ ¡£Ê×ÏÈ £¬ÊÖÊõÓÕ·¢ÀàµÄÄ£×Ó £¬ÊÖÒÕÄѶȴó £¬ÌØÊâÔÚС¶¯ÎïÉϲÙ×÷µÄÒ»ÖÂÐÔÇ·ºÃ¿ØÖÆ £¬¶ø´ó¶¯Îï¹ØÓÚÒ©ÎïÆÀ¼Û²»ÊǺܱ㵱 £¬Ð¡¶¯Îïͬʱ»¹±£´æÐĵç¼à¿ØµÈרҵÒÇÆ÷µÄÏÞÖÆ ¡£ÁíÍâ £¬ÈËÀàÐÄѪ¹ÜÏµÍ³ÌØµãÒÔ¼°ÔÚijЩÇéÐÎÒòËØ£¨ÈçÓ¦¼¤£©Ï·¢²¡µÄÌØµã £¬ÔÚ³£ÓõÄС¶¯ÎïÄ£×ÓÉ϶¼ºÜÄÑÄ£Äâ £¬ÏÖÓÐÄ£×ÓºÍÈËÀ༲²¡µÄÏÖÕæÏàÐβî±ðºÜ´ó ¡£¾¡¿ÉÄÜÄ£ÄâÈËÀ༲²¡µÄ²¡ÒòºÍ²¡Àí»úÖÆ £¬ÎªÑ°ÕÒȱѪÐÔÐÄÔಡµÄ·ÀÖβ½·¥ÌṩºÜºÃµÄÑо¿Æ½Ì¨ £¬ÊÇÕâÀàÄ£×ÓÑо¿µÄÉú³¤Æ«Ïò ¡£

ÓÉÓÚСÊó¶¯ÂöÖàÑùÓ²»¯²¡±äµÄ²¿Î»¾ÖÏÞÓÚ×Ô¶¯Âö £¬Í¨Ë×ÔìÄ£·½·¨²»¿ÉÄ£ÄâÈËÀà¹ÚÐIJ¡×ÔÈ»·¢²¡Àú³Ì £¬Òò´ËСÊóµÄ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ÐÔÐÄÔಡģ×Ó £¬ÖƱ¸ºÜÊÇÄÑÌâ ¡£ÔÚ»ùÒòÐÞÊÎСÊóÄ£×Ó´ó×Ú·ºÆðÒÔºó £¬Ò»Ð©ÌØÊâµÄÄ£×ÓÖð½¥±»·¢Ã÷ÓÐ×Ô¾õÐÔ¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐ£ËÀ»òÕß¾ßÓÐÇéÐÎÖ²¡ÒòËØÒ׸ÐÐÔ ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

 Í¨¹ý¶à»ùÒòÐÞÊÎ £¬ÔÚÓ°ÏìÖ¬´úл¡¢Ñª¹Ü±Úϸ°ûµÈ¶àÖÖ»ùÒò¹¦Ð§Òì³£ÇéÐÎÏ £¬Ôì³ÉºÜÊÇÑÏÖØµÄ¶¯ÂöÖàÑùÓ²»¯ £¬Ê¹²¡±äÖð½¥ÀÛ¼°ÐÄÄÔѪ¹Ü ¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

¶à»ùÒòÐÞÊλù´¡ÉÏ £¬ÔöÌíÒûʳ»òÓ¦¼¤µÈÇéÐÎÒòËØ £¬Ä£ÄâÈËÀà¹Ú×´¶¯ÂöÓ²»¯×ÔÈ»±¬·¢Àú³Ì ¡£

¡¾ÔìÄ£ÌØµã¡¿£º

SR-BI/ApoEË«»ùÒòÇóýСÊó·ºÆðÏÔÖøÉý¸ßµÄ¸ßÃܶÈÖ¬ÂÑ°× £¬¶øÓÎÀ뵨¹Ì´¼ÏÔÖøÉý¸ß £¬Ñª½¬ÖÐ £¬ÆäÓ뵨¹Ì´¼º¨µÄ±ÈÀý(FC/CE)ÏÔÖøÉý¸ß³ÉΪ¸ÃÄ£×ÓµÄÌØµã ¡£¸ÃÄ£×Ó8ÖÜÄÚ»ù±¾¶¼·ºÆð¹Ú×´¶¯ÂöÖàÑùÓ²»¯ºÍÐĹ£ £¬éæÃüÂʼ«¸ß ¡£n/i/eNOSÈý»ùÒòÇóýСÊó³öÉú8¸öÔÂ×óÓÒ°ëÊýÒÔÉÏËÀÓÚÐĹ£ ¡£¸ÃÄ£×ÓѪ½¬µÍÃܶÈÖ¬ÂѰ׵¨¹Ì´¼º¬Á¿Éý¸ß £¬¹Ú×´¶¯Âö±¬·¢ÏÔ×ŵÄÄÚĤÔöÉúºÍÖÐĤ±äºñ £¬¹ÜÖܰé·Ê´óϸ°û½þÈó £¬ÍƲâ¹Ú×´¶¯ÂöÓ²»¯ºÏ²¢¾·Âε¼Ö¸ÃÄ£×ÓÐĹ£ ¡£

ÏÂÃæËùÁеÄÄ£×Ó £¬¾ùÒѾ­±¨µÀÔÚÇéÐÎÒòËØ×÷ÓÃÏ £¬ÌåÏÖ¹Ú×´¶¯ÂöÓ²»¯ºÍÐĹ£ £¬°üÀ¨eNOS/ApoEË«ÇóýСÊó¡¢SR-BI-/-/HypoEСÊó¡¢SR-BI/LDLrË«ÇóýСÊó¡¢uPA-Tg/ApoE-/-СÊó¡¢Akt1/ApoEË«ÇóýСÊó¡¢PDZKI/ApoEË«ÇóýСÊó¡¢ApoE/LDL-RË«ÇóýСÊó ¡£ÕâЩģ×ÓÓи÷×ÔÏà¹ØµÄÖ¬´úÐ»ÌØµã £¬Í¬Ê±¾ßÓÐÔÚ¸ßÖ¬ÒûʳµÈÒòËØµÄ¸ººÉÏ £¬Ò»¶¨Ë®Æ½ÉÏ £¬ÈËΪ¿ØÖÆÐĹ£µÄ±¬·¢Ê±¼äºÍ¹Ú×´¶¯Âö²¡±äˮƽ ¡£

¡¾Ä£×ÓȪԴ¡¿£º

´ó´ó¶¼Ð¡ÊóÄ£×Ó¿ÉÒÔ´ÓÃÀ¹úJacksonʵÑéÊÒ(bttp://www.jax.org/index.html)¡¢MMRRC (Mutant Mouse Regional Resource Centers £¬http:// www.mmrrc.org)ºÍ¹ú¼ÒÒÅ´«¹¤³ÌСÊó×ÊÔ´¿â(http://www.nrcmm.cn/mice/index.asp)»ñµÃ ¡£´Ó±±¾©´óѧҽѧ²¿ÐÄѪ¹ÜÑо¿Ëù¿ÉÒÔ»ñµÃ²¿·Ö¶¯ÎïÄ£×Ó ¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

 »ùÒòÐÞÊÎÊÖÒÕʹ¹ÚÐIJ¡Ð¡ÊóÄ£×ÓÖÆ±¸³ÉΪ¿ÉÄÜ £¬×÷ΪÈËÀà¹ÚÐIJ¡Ô¤·ÀºÍÖÎÁÆÑо¿µÄ¹¤¾ß £¬ÓÉÓÚСÊóÔÚÆÊ½â½á¹¹¡¢´úлµÈÐÄÀí¹¦Ð§µÄµ÷ÀíÉÏÓëÈËÀà±£´æ½Ï´ó²î±ð £¬Æä¹ÚÐIJ¡²¡±äÌØµãÓ벿λºÍÈËÀ಻ÍêȫһÖ £¬Ê¹µÃСÊóÄ£×ÓµÄÓ¦ÓÃÊܵ½Öî¶àÏÞÖÆ £¬ÆÀ¼ÛÐÂÒ©Ò²±£´æ½Ï´óΣº¦ ¡£

ÆäËû¶¯ÎïÈç´óÊó(JCR:LA-cp rat¡¢CETP Tg rat)¡¢µØÊó¡¢¼ÒÍᢸ롢ÖíÒÔ¼°·ÇÈËÁ鳤ÀàµÄºãºÓºï £¬¶¼ÓÐ×Ô¾õ¹Ú×´¶¯ÂöÓ²»¯µÄ±¨µÀ £¬ÌØÊâÊÇ×î½ü±¨µÀµÄPCSK9ת»ùÒòСÐÍÖí £¬ÓÉÓÚÖíÔÚÐÄѪ¹Ü¼²²¡Ä£×ÓÖеÄÌØÊâÓÅÊÆ £¬ÓпÉÄܳÉΪÀíÏëµÄ¹ÚÐIJ¡¶¯ÎïÄ£×Ó ¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅ¿¡Òå £¬ÍõÕýÖÒ £¬´÷ºìÑÞ £¬µÈ£®´óÊóÐ£ËÀÄ£×ÓÖÆ×÷ÒªÁì̽ÌÖ£®Çൺ´óѧҽѧԺѧ±¨ £¬2013,49(2):121-123

2.¹ùˆÅ £¬ºÂΰ £¬Àî·å½Ü £¬µÈ£®BeagleÈ®ÓëÔÓÖÖÈ®¼±ÐÔÐ£ËÀÄ£×ӵĽÏÁ¿£®ÖйúÖÐÒ©ÔÓÖ¾ £¬2013,28 (12):2001-2004

3.Cozen  AE, Moriwaki H, Kremen M, el al. Macrophagetargeted overexpression of urokinase causes acceleratedatherosclerosis,coronary artery occlusions, and premature death. Circulation, 2004,09 (17):2129-2135

4.Cullen P,Baella R,Bellosla S,el al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vase Biol, 2003, 23 (4):535-542

5.Fernandez-Hernando C,Ackah E, Yu J,el al. Loss of Aktl leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab,2007, 6 (6):446-457

6.Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis,aortic aneurysm formation, and ischernic heart disease in apolipoprotein E/endolhelial nitric oxide synthase double-knockout mice. Circulation, 2001, 104 (4):448-454

7.Nakata S, Tsutsui M, Shimokawa H,et al. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation, 2008, 117 (17):2211- 2223

8.Shiomi M,Ito T. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe., Atherosclerosis, 2009, 207 (1):1-7

9.Trigalli B, Rayburn H, Viiials M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A, 1999,96 (16):9322-9327

10.Zhang S,Picard MH, Vasile E,et al. Diel-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction,and premature death in scavenger receptor class B lype 1-deficient,hypomorphic apolipoprotein ER61 mice. Circulation, 2005, 111(25): 3457-3464

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿